Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Touxie Qingfei Decoction for Mild COVID-19 to Prevent Progression
ChiCTR2200058249Phase 2Not yet recruiting
- Sponsor
- Shenzhen Traditional Chinese Medicine Hospital
- Start
- Mar 2022
- Countries
- 1
01
Overview
Phase 2 trial of Touxie Qingfei Decoction in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Shenzhen Traditional Chinese Medicine Hospital. Primary endpoints: Clinical symptom score, Rate of progression from mild to severe COVID-19 and 1 more. Planned start Mar 2022; status: not yet recruiting.
02
Drugs
Touxie Qingfei Decoction
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ChiCTR2200058249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200058249.